Non-SARS-CoV-2 respiratory tract infections in pediatric populations during the pandemic

Yi-Ting Chen1, Ya-Chih Cheng1, Kuo-Chen Weng1

  • 1Department of Laboratory Medicine, National Taiwan University Hospital, Taipei, Taiwan.

Insights

In pediatric patients with non-SARS-CoV-2 respiratory infections, human rhinovirus/enterovirus and human bocavirus were frequently detected. These viral co-detections were associated with asthma, male gender, and fever, highlighting their clinical significance.

Area of Science:

  • Pediatrics
  • Virology
  • Infectious Diseases

Background:

  • Respiratory tract infections (RTIs) pose significant risks to children, necessitating identification of pathogens beyond SARS-CoV-2.
  • Understanding the etiology of RTIs in pediatric patients is crucial for effective clinical management, especially during viral outbreaks.

Purpose of the Study:

  • To investigate the prevalence and clinical associations of viral pathogens in SARS-CoV-2-negative pediatric patients with RTIs.
  • To identify common co-detections and their potential impact on disease presentation and outcomes in children.

Main Methods:

  • Analysis of 156 SARS-CoV-2-negative pediatric RTI cases using multiplex PCR (BIOFIRE® FilmArray® RP 2.1).
  • Specific detection of human rhinovirus/enterovirus (HRV/EV) and human bocavirus (HBoV) using targeted assays.

Main Results:

  • Viral pathogens were detected in 61.5% of cases, with HRV/EV being the most common (92.7% of positive samples).
  • Human bocavirus (HBoV) was detected in 27.8% of samples and associated with age; 45.5% of pneumonia cases were HBoV-positive.
  • Viral co-detections, frequently involving HBoV and HRV/EV, were linked to male gender and fever.

Conclusions:

  • Viral co-infections are common in pediatric non-SARS-CoV-2 RTIs.
  • Rhinovirus and human bocavirus are significant findings requiring further research into their clinical implications in Taiwanese children.
  • The study underscores the importance of comprehensive viral pathogen testing in pediatric respiratory infections.
Abstract

Related Concept Videos

Common Respiratory Disorders01:31

Common Respiratory Disorders

Respiratory disorders, a prevalent health concern globally, are generally divided into two primary categories: upper and lower respiratory tract disorders. The categorization is based on the area of the respiratory system they affect.
Upper respiratory disorders impact the airways above the vocal cords, encompassing areas like the nose, sinuses, and throat. Various conditions fall under this category, including the common cold and allergic rhinitis. These disorders can stem from several causes,...
1.5K
Pharmacokinetics in Pediatric Patients: Drug Excretion01:26

Pharmacokinetics in Pediatric Patients: Drug Excretion

In pediatric medicine, understanding the renal function and drug elimination nuances is crucial for administering safe and effective treatments. Newborns, in particular, display markedly slower renal functions than adults, profoundly affecting how drugs are cleared from their bodies. This slower drug clearance requires clinicians to extend the dosing intervals for many medications to prevent drug accumulation and toxicity while ensuring therapeutic efficacy.One key area where these adjustments...
284
Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption01:23

Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption

Understanding the physiological differences in the pediatric population is crucial for effective pharmacotherapy. Neonates, infants, and children exhibit significant variations in gastric pH, gastric emptying time, intestinal transit time, and biliary function. These variations profoundly affect oral drug absorption, necessitating a nuanced approach to pediatric dosing.Neonates present with a unique physiological profile, having a gastric pH greater than 4 and faster and more irregular gastric...
323
Pharmacokinetics in Pediatric Patients: Drug Metabolism01:24

Pharmacokinetics in Pediatric Patients: Drug Metabolism

In pediatric care, understanding the nuances of hepatic drug metabolism is crucial, as it significantly differs from that of adults. This divergence is primarily due to the developmental stage of drug-metabolizing enzymes, which affects how medications are processed in the body. In neonates, for instance, the activity of Phase I enzymes—critical for the initial breakdown of drugs—is markedly reduced, functioning at just 20–40% of the levels seen in adults. This reduction poses...
256
Pharmacokinetics in Pediatric Patients: Drug Distribution01:17

Pharmacokinetics in Pediatric Patients: Drug Distribution

Drug distribution in the pediatric population exhibits unique challenges and considerations due to the physiological differences between children, particularly neonates and infants, and adults. A crucial aspect of pediatric pharmacology is understanding how these differences impact the pharmacokinetics of various drugs, necessitating age-specific dosing strategies to ensure efficacy and safety.Neonates and infants have a higher total body water content, ~75%–90% of their body weight,...
335
Pneumonia II: Pathophysiology01:29

Pneumonia II: Pathophysiology

The pathophysiology of pneumonia involves the following steps:
3.2K